Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David B Smith

Showing results (31-40 of 58) with videos related to

Pageof 6
Sort By:
Drug Development and Industrial Pharmacy|July 10, 2008
Physicochemical properties of the nucleoside prodrug R1626 leading to high oral bioavailabilityMichael Brandl, Xiaoyang Wu, Marites Holper, et al.
Pharmacology Research & Perspectives|May 9, 2018
Pharmacokinetics, safety, and tolerability of the 2- and 3-direct-acting antiviral combination of AL-335, odalasvir, and simeprevir in healthy subjectsThomas N Kakuda, Matthew W McClure, Christopher Westland, et al.
Journal of Medicinal Chemistry|March 21, 2007
Application of the phosphoramidate ProTide approach to 4'-azidouridine confers sub-micromolar potency versus hepatitis C virus on an inactive nucleosidePlinio Perrone, Giovanna M Luoni, Mary Rose Kelleher, et al.
Bioorganic Chemistry|October 23, 2023
Synthesis and evaluation of highly potent HBV capsid assembly modulators (CAMs)Franck Amblard, Zhe Chen, John Wiseman, et al.
The Science of the Total Environment|March 4, 2016
Surface-air mercury fluxes across Western North America: A synthesis of spatial trends and controlling variablesChris S Eckley, Mike T Tate, Che-Jen Lin, et al.
Bioorganic & Medicinal Chemistry Letters|March 18, 2004
Lactams as EP4 prostanoid receptor subtype selective agonists. Part 1: 2-Pyrrolidinones-stereochemical and lower side-chain optimizationTodd R Elworthy, Denis J Kertesz, Woongki Kim, et al.
Journal of Medicinal Chemistry|April 28, 2016
Synthesis and Anti-Influenza Activity of Pyridine, Pyridazine, and Pyrimidine C-Nucleosides as Favipiravir (T-705) AnaloguesGuangyi Wang, Jinqiao Wan, Yujian Hu, et al.
Edinburgh Medical Journal|April 12, 2018
Address to Professor Syme from IndiaJ P Brougham, F W Innes, H Mitchell, et al.
Journal of Medicinal Chemistry|February 11, 2015
Discovery of 4'-chloromethyl-2'-deoxy-3',5'-di-O-isobutyryl-2'-fluorocytidine (ALS-8176), a first-in-class RSV polymerase inhibitor for treatment of human respiratory syncytial virus infectionGuangyi Wang, Jerome Deval, Jin Hong, et al.
Lancet (London, England)|July 17, 2007
Different strategies of sequential and combination chemotherapy for patients with poor prognosis advanced colorectal cancer (MRC FOCUS): a randomised controlled trialMatthew T Seymour, Timothy S Maughan, Jonathan A Ledermann, et al.
Pageof 6

Showing results (31-40 of 58) with videos related to

Sort By:
Pageof 6
Drug Development and Industrial Pharmacy|July 10, 2008
Physicochemical properties of the nucleoside prodrug R1626 leading to high oral bioavailabilityMichael Brandl, Xiaoyang Wu, Marites Holper, et al.
Pharmacology Research & Perspectives|May 9, 2018
Pharmacokinetics, safety, and tolerability of the 2- and 3-direct-acting antiviral combination of AL-335, odalasvir, and simeprevir in healthy subjectsThomas N Kakuda, Matthew W McClure, Christopher Westland, et al.
Journal of Medicinal Chemistry|March 21, 2007
Application of the phosphoramidate ProTide approach to 4'-azidouridine confers sub-micromolar potency versus hepatitis C virus on an inactive nucleosidePlinio Perrone, Giovanna M Luoni, Mary Rose Kelleher, et al.
Bioorganic Chemistry|October 23, 2023
Synthesis and evaluation of highly potent HBV capsid assembly modulators (CAMs)Franck Amblard, Zhe Chen, John Wiseman, et al.
The Science of the Total Environment|March 4, 2016
Surface-air mercury fluxes across Western North America: A synthesis of spatial trends and controlling variablesChris S Eckley, Mike T Tate, Che-Jen Lin, et al.
Bioorganic & Medicinal Chemistry Letters|March 18, 2004
Lactams as EP4 prostanoid receptor subtype selective agonists. Part 1: 2-Pyrrolidinones-stereochemical and lower side-chain optimizationTodd R Elworthy, Denis J Kertesz, Woongki Kim, et al.
Journal of Medicinal Chemistry|April 28, 2016
Synthesis and Anti-Influenza Activity of Pyridine, Pyridazine, and Pyrimidine C-Nucleosides as Favipiravir (T-705) AnaloguesGuangyi Wang, Jinqiao Wan, Yujian Hu, et al.
Edinburgh Medical Journal|April 12, 2018
Address to Professor Syme from IndiaJ P Brougham, F W Innes, H Mitchell, et al.
Journal of Medicinal Chemistry|February 11, 2015
Discovery of 4'-chloromethyl-2'-deoxy-3',5'-di-O-isobutyryl-2'-fluorocytidine (ALS-8176), a first-in-class RSV polymerase inhibitor for treatment of human respiratory syncytial virus infectionGuangyi Wang, Jerome Deval, Jin Hong, et al.
Lancet (London, England)|July 17, 2007
Different strategies of sequential and combination chemotherapy for patients with poor prognosis advanced colorectal cancer (MRC FOCUS): a randomised controlled trialMatthew T Seymour, Timothy S Maughan, Jonathan A Ledermann, et al.
Pageof 6